A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized MSS rectal cancer

被引：0
|
作者：
Kossler, Thibaud
Nicolas, Buchs
Dutoit, Valerie
Puppa, Giacomo
Tsantoulis, Petros
Frossard, Jean-Louis
Bichard, Philippe
Montet, Xavier
Mckee, Thomas
Di Marco, Mariagrazia
Dietrich, Pierre-Yves
Roth, Arnaud
Zilli, Thomas
Ris, Frederic
机构：
[1] Geneva Univ Hosp, Geneva, Switzerland
[2] Geneva Univ Hosp, Ctr Oncol, Geneva, Switzerland
[3] Hop Univ Geneve, Geneva 14, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
[5] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS272
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PEMREC: A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized microsatellite stable rectal cancer
    Kossler, T.
    Buchs, N.
    Dutoit, V.
    Puppa, G.
    Tsantoulis, P.
    Frossard, J.
    Bichard, P.
    McKee, T.
    Di Marco, M.
    Dietrich, P.
    Roth, A.
    Zilli, T.
    Ris, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S127 - S127
  • [2] Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer
    Corro, Claudia
    Buchs, Nicolas C.
    Tihy, Matthieu
    Durham-Faivre, Andre
    Bichard, Philippe
    Frossard, Jean-Louis
    Puppa, Giacomo
    McKee, Thomas
    Roth, Arnaud
    Zilli, Thomas
    Trembleau, Christelle
    Di Marco, Mariagrazia
    Dutoit, Valerie
    Dietrich, Pierre-Yves
    Ris, Frederic
    Koessler, Thibaud
    BMC CANCER, 2022, 22 (01)
  • [3] Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer
    Claudia Corrò
    Nicolas C. Buchs
    Matthieu Tihy
    André Durham-Faivre
    Philippe Bichard
    Jean-Louis Frossard
    Giacomo Puppa
    Thomas McKee
    Arnaud Roth
    Thomas Zilli
    Christelle Trembleau
    Mariagrazia Di Marco
    Valérie Dutoit
    Pierre-Yves Dietrich
    Frédéric Ris
    Thibaud Koessler
    BMC Cancer, 22
  • [4] Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer
    Boussen, Hamouda
    Cristofanilli, Massimo
    Zaks, Tal
    DeSilvio, Michelle
    Salazar, Vanessa
    Spector, Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3248 - 3255
  • [5] Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
    Willett, Christopher G.
    Duda, Dan G.
    di Tomaso, Emmanuelle
    Boucher, Yves
    Ancukiewicz, Marek
    Sahani, Dushyant V.
    Lahdenranta, Johanna
    Chung, Daniel C.
    Fischman, Alan J.
    Lauwers, Gregory Y.
    Shellito, Paul
    Czito, Brian G.
    Wong, Terence Z.
    Paulson, Erik
    Poleski, Martin
    Vujaskovic, Zeljko
    Bentley, Rex
    Chen, Helen X.
    Clark, Jeffrey W.
    Jain, Rakesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3020 - 3026
  • [6] Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
    Zuleyha Akgun
    Sezer Saglam
    Serap Yucel
    Zeynep Gural
    Emre Balik
    Gokhan Cipe
    Seyma Yildiz
    Sadettin Kilickap
    Alper Okyar
    Esra Kaytan-Saglam
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 751 - 756
  • [7] Phase II study of neoadjuvant treatment of rectal cancer with oxaliplatin, raltitrexed and radiotherapy.
    Casado, E
    De Castro, J
    Castelo, B
    Sanchez, B
    Feliu, J
    Escribano, A
    García-Olmo, D
    Redondo, A
    Sereno, CBM
    Baron, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 305S - 305S
  • [8] Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
    Akgun, Zuleyha
    Saglam, Sezer
    Yucel, Serap
    Gural, Zeynep
    Balik, Emre
    Cipe, Gokhan
    Yildiz, Seyma
    Kilickap, Sadettin
    Okyar, Alper
    Kaytan-Saglam, Esra
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 751 - 756
  • [9] Efficacy and safety of camrelizumab and apatinib combined with neoadjuvant concurrent chemoradiation for MSS locally advanced rectal cancer
    Jiang, Tao
    Wang, Dongsheng
    Cheng, Jingjing
    Wei, Xiaojuan
    Fu, Jialei
    Cao, Lianjing
    Lei, Peijie
    Zhang, Xianxiang
    Gao, Yuan
    Hu, Jilin
    Zhang, Hongjun
    Cao, Bin
    He, Baoguo
    Mao, Qingdong
    Qi, Peng
    Wang, Jigang
    Zhou, Xiaoming
    Tan, Junying
    Lu, Haijun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] The efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Zhang, Yongchun
    Jiang, Peng
    Zhu, Hui
    Dong, Bin
    Zhai, Hanxiao
    Chen, Zhiying
    Chen, Zhiying
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1531 - 1542
12345